This study utilizes the dual‐recombinase system‐driven genetic mouse model of spontaneous pancreatic cancer in combination with fluorescence‐switching reporters and mesenchymal fate mapping transgenes (αSMA‐Cre and Fsp1‐Cre), to lineage trace EMT program. This evidence concerns the gene S100A4 and familial pancreatic carcinoma.